Summary Vitamin D deficiency has been associated with increased risk for cardiovascular disease and anemia. Vitamin D-related changes in lipid profile have been studied extensively but the relationship between vitamin D and lipid metabolism is not completely understood. As both vitamin D and intermittent training may potentially affect iron and lipid metabolism, the aim of the study was to evaluate whether a daily supplementation of vitamin D can modulate the response of hematological and lipid parameters to high-intensity interval training (HIIT) in soccer players. Thirty-six young elite junior soccer players were included in the placebo-controlled, double-blind study. Participants were non-randomly allocated into either a supplemented group (SG, n520, HIIT and 5,000 IU of vitamin D daily) or placebo group (PG, n516, HIIT and sunflower oil). Hematological parameters were ascertained before and after the 8-wk training. The change score (post-and pre-training difference) was calculated for each individual and the mean change score (MCS) was compared between SG and PG using the t test and analysis of covariance. There were no differences between SG and PG at baseline. The red and white cell count, hemoglobin, hematocrit, MCHC, ferritin, and HDL-cholesterol changed significantly over the 8-wk HIIT. However, no significant differences in MCS were observed between SG and PG for any variable. A daily vitamin D supplement did not have any impact on alteration in hematological or lipid parameters in young soccer players in the course of high-intensity interval training. Key Words nutrition, athletic training, sport, interval training, intermittent exercise In recent years, vitamin D has been the subject of intensive research with the primary goal of identifying and understanding its roles beyond the bones, such as cancer, immunity, cardiovascular risk, erythropoiesis, muscle function and athletic performance, to name a few (1, 2). Several lines of evidence, observational studies in particular, suggest that vitamin D lowers the risk of cardiovascular disease (3, 4). Numerous mechanistic explanations for this effect are proposed, such as change in insulin resistance, inflammatory reactions, and parathyroid hormone (PTH), renin and blood pressure levels (5). In addition, owing to a well-known relationship between dyslipidemia and atherosclerotic disease as well as a high prevalence of both vitamin D deficiency and cardiovascular disease, vitamin D-dependent changes in lipid profile have recently been given much attention (6). However, the relationship between vitamin D and lipid metabolism is not completely understood (7-10). Moreover, found that genetically reduced plasma 25-hydroxyvitamin D (25(OH)D) is not associated with increased risk of ischemic heart disease. Moreover, the results of Scragg et al.'s (12) randomized controlled trial (RCT) study showed no evidence that monthly high-dose vitamin D supplementation (100,000 IU a month) prevented cardiovascular diseases.
In recent years, vitamin D has been the subject of intensive research with the primary goal of identifying and understanding its roles beyond the bones, such as cancer, immunity, cardiovascular risk, erythropoiesis, muscle function and athletic performance, to name a few (1, 2) . Several lines of evidence, observational studies in particular, suggest that vitamin D lowers the risk of cardiovascular disease (3, 4) . Numerous mechanistic explanations for this effect are proposed, such as change in insulin resistance, inflammatory reactions, and parathyroid hormone (PTH), renin and blood pressure levels (5) . In addition, owing to a well-known relationship between dyslipidemia and atherosclerotic disease as well as a high prevalence of both vitamin D deficiency and cardiovascular disease, vitamin D-dependent changes in lipid profile have recently been given much attention (6) . However, the relationship between vitamin D and lipid metabolism is not completely understood (7) (8) (9) (10) . Moreover, Brøndum-Jacobsen et al. (11) found that genetically reduced plasma 25-hydroxyvitamin D (25(OH)D) is not associated with increased risk of ischemic heart disease. Moreover, the results of Scragg et al.'s (12) randomized controlled trial (RCT) study showed no evidence that monthly high-dose vitamin D supplementation (100,000 IU a month) prevented cardiovascular diseases.
In cross-sectional observational studies, lower p-25(OH)D, an indicator of vitamin D status (13) , has been associated with unfavorable plasma lipid profiles, including total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) (14) (15) (16) . In adolescents, meta-analysis of observational studies indicated that adequate vitamin D status was found to be associated with a favorable lipid profile (17) . However, despite the promising results of the observational studies, randomized trials and their meta-analyses were much less convincing (10) .
Vitamin D receptor (VDR) was found in bone marrow (18) and both 25(OH)D and 1,25-dihydroxyvitamin D (1-25(OH)D, calcitriol, the active form of vitamin D) con-tent in the cellular fraction of bone marrow (hematon) is much higher than in the bone marrow plasma (19) . Accumulating evidence suggests a role for vitamin D in erythropoiesis. In particular, vitamin D deficiency was associated with a greater risk of anemia, lower hemoglobin levels and use of erythrocyte-stimulating agents in community-dwelling individuals (20) and in subjects with chronic kidney disease (21, 22) . Recently, Atkinson et al. (23) reported similar relationships in healthy children and adolescents. Several possible mechanisms for the association between vitamin D and anemia have been proposed, such as a direct stimulatory proliferative effect of vitamin D on bone marrow cells via VDR (24) , silencing of inflammatory reactions that lead to anemia or chronic diseases (25) or parathyroid hormone (PTH)-dependent alteration in erythrocyte osmotic resistance (26) . However, so far, the results of observational studies have not been confirmed by RCT (27) (28) (29) . In a recent randomized control trial, Ernst et al. (27) found no effect of daily vitamin D supplementation (2,800 IU) for 8 wk on hemoglobin level or the reduction of risk of anemia in non-anemic hypertensive patients with various vitamin D statuses. In addition, 12-wk vitamin D supplementation (600,000 IU once) did not improve the outcomes of parenteral iron therapy in subjects with both vitamin D deficiency and iron deficiency anemia (29) .
Several studies have looked into the effect of intermittent training on total cholesterol, HDL-C, LDL-C, TG (30) (31) (32) (33) (34) (35) or VLDL, HDL and LDL lipoprotein particles (36) . However, only a few studies examined the effect of interval training on iron metabolism. Previous studies reported that intense interval training session may cause a significant increase in transferrin and serum iron (37, 38) . Furthermore, Wilkinson et al. (39) reported that 6-wk high-intensity interval training can reduce iron stores in male cyclists. Similarly, Kortas et al. (40) reported that 32-wk Nordic walking training significantly reduced the blood ferritin concentration in elderly people. Taken together, both vitamin D and interval training may potentially affect the lipid and iron metabolism. Therefore, the goal of the present study was to evaluate whether an 8-wk daily supplementation of vitamin D can modulate the response of hematological and lipid parameters to high-intensity interval training (HIIT) in well-trained young soccer players.
MATERIALS AND METHODS
Thirty-six top junior soccer players, school dormitory residents, aged 17.560.6 y, body mass 71.366.9 kg, BMI 22.261.8 kg/m 2 , were included in the placebocontrolled, double-blind study. The experimental procedures have been described in details previously (41) . The study protocol was approved by Ethical Committee of the local Medical Association in Gdańsk (Nr KB-1/14). All players and their parents or legal guardians were provided with detailed information about the study procedures and gave their written consent.
Training program. The experiment was conducted during an 8-wk training cycle of the preparatory season in winter, within the time of inadequate UVB exposure.
Participants nourished in the same way, were non-randomly allocated into either an experimental group (SG, n520, subjected to training and cholecalciferol supplementation) or placebo group (PG, n516, doing training only). The selection to the groups was guided by the peak power (W/kg) using the Wingate test (42) and PWC170 index (kgm/kg/min) using PWC170 test (43) measures obtained prior to the experiment. The training regimen was the same for all subjects and has been thoroughly described previously (41) . All the players were subjected to the same soccer training described as high-intensity interval training (HIIT) that involved endurance, speed and strength drills. Small-sided games and interval runs at the anaerobic threshold (AnT) were performed on a field with a synthetic surface. The intensity of the effort was determined by heart rate (HR) that was equal to or higher than the AnT value but did not exceed 90% HRmax. Small-sided games were performed on a field measuring 32322 m (3 vs 3 on Tuesday) or 44333 m (6 vs 6 on Thursday) with 120 m 2 of the surface per player. The subjects of both groups played 4 games, 4 min each with a 3-min active break that involved marching and muscle relaxing drills. On Fridays, the players performed 4 series, 5 min each, of interval running with a 3-min active break (like that during the small-sided games). On the other days of the 1-wk training cycle the players were subjected to technical tactical, speed and explosive strength drills. The participation in training sessions was 95%.
Supplementation. Subjects from the supplemented group were given a vitamin D3 bottle (Vigantol Merck, Darmstadt, Germany), whereas the placebo group received identical bottles with sunflower oil. All participants were asked to take 10 droplets per day (around 5,000 IU of vitamin D daily in the supplemented group) in the morning. Before, during and after the experiment, the tested subjects lived in the school dormitory and were nourished in the same way. The diet of the players was standard but included increased amount of vegetables, fruit and dairy products (sports diet). One month before and during the experiment the players did not take any vitamins or other sports supplements.
Biochemical and hematological analyses. Biochemical and hematological analyses were performed before and after the training program. A 4.9 mL S-Monovette tube with ethylenediaminetetraacetic acid (K3 EDTA; 1.6 mg EDTA/mL blood) and separating gel (Sarstedt Ag & Co., Nümbrecht, Germany) were used. For the complete blood count, a 2.6 mL S-Monovette tube with K3 EDTA (1.6 mg EDTA/mL blood) was used. Blood samples for biochemical analyses were centrifuged 300 3g for 15 min at room temperature in order to obtain blood plasma. The analyses were performed immediately after the blood collection. Complete blood count, including white blood cells (WBC), red blood cells (RBC), hemoglobin (HGB), hematocrit (HTC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and total platelet level (PLT) were obtained using Sysmex K-4500 Hematology Analyzer (Toa Sysmex, Kobe, Japan).
Lipid profile analyses were conducted using Random Access Automatic Biochemical Analyzer for Clinical Chemistry and Turbidimetry A15 (Bio-Systems S.A., Barcelona, Spain). Blood plasma was used to determine the lipid profile: TC, TG, HDL-C and LDL-C concentrations. Plasma TG and TC concentrations were determined using the diagnostic colorimetric enzymatic method according to the manufacturer's protocol (BioMaxima S.A., Lublin, Poland). The manufacturer's declared intra-assay coefficients of variation (CV) for the method were ,2.5% and ,1.5% for the TG and TC determinations, respectively. The HDL-C plasma concentration was determined using human anti-b-lipoprotein antibody and the colorimetric enzymatic method according to the manufacturer's protocol (BioMaxima S.A.). The manufacturer's declared intra-assay CV for the method was ,1.5%. Plasma concentrations of LDL-C were determined using a direct method according to the manufacturer's protocol (PZ Cormay S.A., Lomianki, Poland). The manufacturer's declared intraassay CV for the method was 4.97%. Plasma 25(OH)D concentration (range, 50-125 nmol/L) was determined by the standard method of Biomèrieux, Marcy-I'Etoile, France (kit 30463) using mini Vidas analyzer. The manufacturer's declared intra-assay CV for the method was 2.4-6.4% respective to the range. Plasma ferritin concentration (range, 30-350 ng/mL) was assessed by an analyser mini Vidas using the enzyme immunology method with ferritin kit 30411 (Biomèrieux). The manufacturer's declared intra-assay CV for the method was 4.0-6.2% respective to the range.
All analysis procedures were verified with the use of multiparametric control serum (Biolabo S.A.S., Maizy, France), as well as control serum of normal level (BioNormL) and high level (BioPathL) lipid profiles (BioMaxima S.A.).
Statistical analyses. Baseline (pre-training) values were compared using an independent sample t test, whereas the training responses were analyzed with a paired t test (for SG, PG or combined SG and PG). Next, the change score (post-and pre-training difference) was calculated for each individual and the mean change score (MCS) was compared between SG and PG with the t test for unequal variances as well as analysis of covariance (ANCOVA) with the pre-training value as a covariate. The mean change score in non-supplemented individuals was subtracted from the mean change score in supplemented individuals (difference in mean change score, DMCS) and was standardized (standardized difference in mean change score, SDMCS) with a pre-training standard deviation (SD) calculated for combined SG and PG. Both MCS and SMCS were reported with 95% confidence limits. The other analyses were performed using STATISTICA (StatSoft, Inc. (2014), version 12, www. statsoft.com) were used. A p value ,0.05 was considered significant.
RESULTS
Baseline parameters, including 25(OH)D, did not differ between the supplemented and non-supplemented group (Table 1) . Twenty-two subjects (61.1%) had a baseline 25(OH)D level ,50 nmol/L (12 in the SG, and 10 in the PG). In the vitamin D-supplemented group (SG), the 25(OH)D increased from 48.568.6 to 106.3626.6 nmol/L (p,0.0001), whereas in the control group it decreased from 47.5616.2 to 43.5616.9 nmol/L (p50.228). The pre-and post-training hematological and lipid parameters as well as mean change scores (MCS) are shown in Table 2 . Except for MCH, platelets (PLT), TC, TG and LDL-C, other parameters changed significantly over an 8-wk period of high-intensity interval period. When training responses were analyzed with respect to supplementation status, no significant differences in mean change scores (MCS) between the supplemented and placebo group were observed (Table 3) . 
DISCUSSION
In the present study, we were unable to find any effect of daily supplementation of 5,000 IU of vitamin D on lipid or hematological parameters, following 8 wk of high-intensity interval training in soccer players. These results corroborate our previous observation of a lack of effect of iron-deficiency vitamin D on training-induced improvements in strength and explosive power-related characteristics (41) . According to the Institute of Medicine of the National Academies, the upper tolerable vitamin D intake level for healthy adults has been set at 4,000 IU a day (44) . Nevertheless, the Endocrine Society set this limit at 10,000 IU per day (45) . Moreover, some experts claimed that a daily intake of 10,000 IU would take months, or years to display symptoms of toxicity (46) . Additionally, Farrokhyar et al. (47) , in a current review study, indicated that for athletes with low baseline values of 25(OH)D, supplementation between 3,000 and 5,000 IU seem to be sufficient for significantly increasing its level during winter months. Therefore, the daily vitamin D dose of 5,000 IU seems to be considered as acceptable for short-duration supplementation.
HIIT led to decreased red cell count, hemoglobin concentration and hematocrit. In addition, we found a significant decrease in the MCHC and ferritin, by 0.7% and 30% respectively. However, all these indicators have remained well within normal ranges, and apart from ferritin these changes were rather small (RBC-2.9%, HGB-2.8%, HTC-2.0%). Many previous studies examined the changes in iron status with relation to endurance training, and both iron deficiency (48, 49) and iron-deficiency anemia (48, 50) have been reported. On the other hand, other studies found no differences in hematological variables when endurance and power athletes were compared with sedentary controls (51) . However, only a few studies have sought to examine the short-term or long-term alteration of iron metabolism as a result of interval training (37-39). Wilkinson et al. (39) found a 25% reduction in ferritin (accompanied by an increase in the total iron binding capacity which reflects transferrin) in male cyclists following 6 wk of high-intensity interval training. In the present study, we found a similar decline (30%) in ferritin level; however, post-exercise ferritin (42.9622.9 ng/mL) was about two times the level indicating iron deficiency (20 ng/mL Wilkinson). Serum iron and transferrin tend to rise during or immediately after interval exercise in trained men (37, 38) . Gray et al. (38) demonstrated a 25% increase in serum iron after a single bout of interval exercise. While the rise in transferrin can be largely attributed to hemoconcentration, other mechanisms have been proposed to explain the elevation in serum iron (38) , for example an inability of the transferrin to absorb iron owing to its maximum saturation (37) . Interestingly, higher serum iron could lead to faster iron elimination (e.g. urinary excretion) (37) , and consequently to an iron depletion as reflected by decreased ferritin levels in the long-term perspective observed in the present and Wilkinson et al.'s study (39) . Of note, ferritin levels were not significantly altered either immediately post-test or 1, 6, or 24 h post-test (38) . The serum 25-hydroxyvitamin D levels have been inversely correlated with hepcidin, which prevents iron efflux from macrophages, the key cells in iron metabolism, by binding to ferroportin receptor, the only iron exporter (52) . It is plausible that vitamin D-supplemented subjects would manifest a greater increase in serum iron than unsupplemented ones in response to interval training; however, serum iron was not examined in the present study.
Except for a 4.3% decline in HDL-C, we did not find any favorable significant effect of HIIT on lipid profile in the combined supplemented and non-supplemented group. Moreover, the plasma lipid changes, including HDL-C, did not differ between SG and PG. Several studies have looked into the effect of intermittent training on total cholesterol, HDL-C, LDL-C, TG (30) (31) (32) (33) (34) (35) 53) or VLDL, HDL and LDL lipoprotein particles (36) . HIIT was shown to activate AMP-activated protein kinase (AMPK) and p38 mitogen-activated protein kinase (MAPK), thereby increasing the capacity for glucose and fatty acid oxidation (54, 55) . The studies that examined the effect of intermittent training on plasma lipids or lipoproteins provided equivocal results, however; they differ largely with respect to training protocols (sprint, ergometer cycling, intensity, interval length from 8 s to 6 min, work : rest ratio), duration (from 8 wk to 18 mo), subjects investigated (usually sedentary individuals with comorbidities such as metabolic syndrome, obesity, essential hypertension), baseline lipid levels and work-to-rest ratio. The longer continuous interval and/or higher work : rest ratio has been suggested to be more effective in raising HDL-C and lowering TG in response to intermittent training (53) . The studies demonstrating the increase in HDL-C used work : rest intervals .1 (34) or 1 : 1 (31, 54) , whereas ratios ,1 were ineffective (30, 31, 35, 56) . Musa et al. (53) found a significant 18% increase in HDL-C and 18% decrease in atherogenic index (TC/HDL-C) in young untrained men in response to 8 wk of 1 : 1 work : rest training with an interval length of 4-5 min. Nonetheless, no effects on HDL-C or TG were demonstrated in a similar study (1 : 1 work : rest, interval time 4 min) by Thomas et al. (57) . Recently, Ouerghi et al. (34) examined the effect of a 12-wk short-short (15 : 15 s) high-intensity intermittent training protocol on lipid profile and aerobic capacity in soccer players. Although not significant, TG decreased by 8%, while total and LDL cholesterol fell by 2%. These results are in a broad agreement with our study. It is noteworthy that both studies were similar with respect to participants studied, training protocol and duration. In this context, a decrease in the HDL-C over an 8-wk HIIT is surprising. It is not clear whether HIIT may be associated with greater variability of HDL-C responses as seen, for example, following endurance training where HDL-C response has been shown to vary from a 9.3% decrease to an 18.3% increase (58) . In addition, the exercise-induced change in HDL-C may be also modulated by other factors such as baseline TG level (59) .
Despite a few possible metabolic mechanisms translating vitamin D action into a favorable lipid profile (60) , convincing evidence that vitamin supplementation improves the lipid level in blood is still lacking. In particular, from 19 randomized controlled trials examining the effects of single dose, periodical or daily supplementation of vitamin D on plasma lipids, only one (60) demonstrated a decrease in LDL-C, but only in the statintreated group. Moreover, the free serum 25(OH)D, but not total 25(OH)D was inversely correlated with TG, TC and LDL-C in this group (59) . Interestingly, several RCT studies showed negative effects on the plasma lipid profile (7, (61) (62) (63) . In addition, in the meta-analysis of 10 RCTs consisting of 1,346 individuals, the vitamin D supplementation was associated with a significant increase in LDL-C, while the TC, TG and HDL-C were not modified significantly (10) . It should be mentioned that in all 10 studies, achieved serum 25(OH)D level in the supplemented groups was greater than 50 nmol/L (51.0-140.0, median 77.6 nmol/L, in this study 67.1-164.7, median 98.1 nmol/L). However, in 6 RCT studies the final post-supplementation 25(OH)D level was between 50 and 80 nmol/L (insufficiency) (64) , and only one study achieved the optimal level (.100 nmol/L), even though no effect on LDL-C, TC, HDL-C or TG was found (13) . In two studies, similar to the present study, a vitamin D dose was used (4,000-5,000 IU/d) and no effects on TC, TG, LDL, or HDL were found, despite the longer duration, 12 wk (65) and 6 mo (66).
In conclusion, the 8-wk daily oral supplementation of vitamin D did not have any impact on alteration in hematological or lipid parameters in young soccer players in the course of high-intensity interval training. Although our research contained some limitations (nonrandomized trial and short duration of applied training program), it confirmed the unfavorable long-term effect of HIIT on iron status, including a 30% decrease in the iron-storage protein ferritin.
